Activation of CD44 facilitates DNA repair in T-cell lymphoma but has differential effects on apoptosis induced by chemotherapeutic agents and ionizing radiation

Leukemia and Lymphoma

Volumn 46, Issue 12, 2005, Pages 1785-1795

  Chen, Caleb ^a,b   Chang, M C ^b   Hsieh, R K ^b   Chang, Y F ^b   Lin, J ^b   Tsan, K W ^b  

^a Nursing   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; CD44s; DNA repair; T cell lymphoma

Indexed keywords

CYCLINE; DEXAMETHASONE; DNA; EPIRUBICIN; HERMES ANTIGEN; HYALURONIC ACID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL POPULATION; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DNA REPAIR; DNA SYNTHESIS; EXCISION REPAIR; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IONIZING RADIATION; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; T CELL LYMPHOMA;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD44; APOPTOSIS; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; DNA REPAIR; FLOW CYTOMETRY; HUMANS; LIGANDS; LYMPHOMA, T-CELL; MICE; SURVIVAL ANALYSIS;

EID: 32144460467     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190500232501     Document Type: Article

References (42)

1. Naor, D and Sionov, R and Ish-Shalon, D. (1997) CD44: Structure, function and association with malignant process Advanced Cancer Research, 72, pp. 241 - 319.
2. Haynes, B and Telen, M and Hale, L and Denning, S. (1989) CD44-A molecule involved in leukocytes adherence and T-cell activation Immunology Today, 10, pp. 423 - 428.
3. Galandrini, R and Albi, N and Tripodi, G and Zarcone, D and Terenzi, A and Moretta, A. (1993) Antibodies to CD44 trigger effect or functions of human T cell clones Journal of Immunology, 150, pp. 4225 - 4235.
4. Salles, G and Zain, M and Jiang, W and Boussiotis, V and Shipp, M. (1993) Alternatively spliced CD44 transcripts in diffuse large-cell lymphomas: Characterization and comparison with normal activated B cells and epithelial malignancies Blood, 82, pp. 3539 - 3547.
5. Ristamaki, R and Joensuu, H and Soderstom, K and Jalkanen, S. (1995) CD44v6 expression in non-Hodgkin's lymphoma: An association with low histological grade and poor prognosis Journal of Pathology, 176, pp. 259 - 267.
6. Pals, S and Horst, E and Ossekoppele, G and Figdor, C and Scheper, R and Meijer, C. (1989) Expression of lymphocyte homing receptor as a mechanism of dissemination in non-Hodgkin's lymphoma Blood, 73, pp. 885 - 888.
7. Jalkanen, S and Joensuu, H and Klemi, P. (1990) Prognostic value of lymphocyte homing receptor and S phase fraction in non-Hodgkin's lymphoma Blood, 75, pp. 1549 - 1556.
8. Sy, M and Guo, Y and Stamenkovic, I. (1991) Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein Journal of Experiment Medicine, 174, pp. 859 - 866.
9. Wang, Y and Rea, T and Bian, J and Gray, S and Sun, Y. (1999) Identification of the genes responsive to etoposide-induced apoptosis: application of DNA chip technology FEBS Journal, 445, pp. 269 - 273.
10. Chaudhry, A and Gobl, A and Eriksson, B and Skogseid, B and Oberg, K. (1994) Different splice variants of CD44 are expressed in gastrinoma but not in other subtypes of endocrine pancreatic tumors Cancer Research, 54, pp. 981 - 986.
11. Bartolazzi, A and Jackson, D and Bennelt, K and Aruffo, A and Dickison, R and Shields, J and (1995) Regulation of growth and dissemination of a human lymphoma by CD44 splice variants Journal of Cell Science, 108, pp. 1723 - 1733.
12. Driessens, M and Stroeken, P and Erena, N and van der Valk, M and van Rijithoven, E and Roos, E. (1995) Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity Journal of Cell Biology, 131, pp. 1849 - 1855.
13. Ayroldi, E and Cannarile, L and Migliorati, G and Bartoli, A and Nicoletti, I and Riccadi, C. (1995) CD44 (Pgp-1) inhibits CD3 and dexamethasone-induced apoptosis Blood, 86, pp. 2672 - 2678.
14. Guy, R and Yefenof, E and Naor, D and Dorogin, A and Ziolberman, Y. (2002) CD44 co-stimulates apoptosis in thymic lymphomas and T cell hybridomas Cellular Immunology, 216, pp. 82 - 92.
15. Liu, K and Kasper, M and Bierhaus, A and Langer, S and Peterson, I and Muller, M. (1997) Differential expression of CD44s and CD44v10 proteins and sydeean in normal and irradiated mouse epidermis Histochemistry and Cell Biology, 107, pp. 159 - 167.
16. Wu, Z and Chen, C and Eastman, S and Bresnick, E. (1991) Expression of human O6-methylguanine-DNA methyltransferase in Chinese hamster ovary cells and restoration of cellular resistance to certain N-nitroso compound Molecular Carcinogenesis, 4, pp. 482 - 488.
17. Dabholkar, M and Vionnet, J and Bostick-Bruton, F and Yu, J and Reed, E. (1994) Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy Journal of Clinical Investigation, 94, pp. 703 - 708.
18. Koberle, B and Master, J and Hartley, J and Wood, R. (1999) Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumors Current Biology, 9, pp. 273 - 276.
19. Kartalou, M and Essigmann, J. (2001) Mechanism of resistance to cisplatin Mutation Research, 478, pp. 23 - 43.
20. Lai, G and Ozols, R and Smyth, J and Young, R and Hamilton, T. (1988) Enhanced DNA repair and resistance to cisplatin in human cancer Biochemical Pharmacology, 37, pp. 4597 - 4600.
21. Selden, J and Dolbeare, F and Clair, J and Nichols, W and Miller, J and Kleemeyer, K. (1993) Statistical confirmation that immunofluorescent detection of DNA repair in human fibroblasts by incorporation is stoichiometric and sensitive Cytometry, 14, pp. 154 - 167.
22. Lesley, J and Schulte, R and Hyman, R. (1990) Binding of hyaluronic acid to lymphoid cell lines is inhibited by monoclonal antibodies against Pgp-1 Experiment Cell Research, 187, pp. 224 - 233.
23. Li, R and Walker, J and Johnson, P. (1998) Chimeric CD4/CD44 molecules associated with CD44 via the transmembrane region and reduce hyaluronan binding in T cell lines European Journal of Immunology, 28, pp. 1745 - 1754.
24. Fujita, Y and Kitagawa, M and Nakamura, S and Azuma, K and Ishii, G and Higashi, M. (2002) CD44 signaling through focal adhesion kinase and its anti-apoptotic effect FEBS Letters, 528, pp. 101 - 108.
25. Okamoto, I and Kawano, Y and Murakami, D and Saayama, T and Araki, N and Miki, T and (2001) Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway Journal of Cell Biology, 155, pp. 755 - 762.
26. Shi, M and Dennis, K and Peschon, J and Chandrasekaran, R and Mikecz, K. (2001) Antibody-induced shedding of CD44 from adherent cells is linked to the assembly of the cytoskeleton Journal of Immunology, 167, pp. 123 - 131.
27. Schein, P and DeVita, V, Jr and Hubbard, S and Young, R. (1976) Bleomycin, adriamycin, cyclophosphamide, vincristine and prednisolone (BACOP) combination chemotherapy in the treatment of advance diffuse histiocytic lymphoma Annals of Internal Medicine, 85, pp. 417 - 422.
28. Haimoritz-Friedman, A and Kan, C and Ehleiter, D and Persand, R and McLoughlin, M and Fuks, Z. (1994) Ionizing radiation acts on cellular membrane to generate uramide and initiate apoptosis Journal of Experiment Medicine, 180, pp. 525 - 535.
29. Huschtscha, L and Bartier, W and Ross, C and Talttersall, M. (1996) Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro British Journal of Cancer, 73, pp. 54 - 60.
30. Waga, S and Hannon, G and Beach, O and Stillman, B. (1994) The p21 inhibitor of cyclin-dependent kinase controls DNA replication by interaction with PCNA Nature, 369, pp. 574 - 578.
31. WAF/Cip1 reflecting proliferation and repair activity in UV-irradiated melanocytic nevi Human Pathology, 29, pp. 1480 - 1487.
32. Friedberg, E. (2001) How nucleotide excision repair protects against cancer Nature Review of Cancer, 1, pp. 22 - 33.
33. Murray, D and Vallee-Lucic, L and Rosenberg, E and Andersson, B. (2002) Sensitivity of nucleotide excision repair-deficient human cells to ionizing radiation and cyclophosphamide Anticancer Research, 22, pp. 21 - 26.
34. Rothman, B and Blue, M and Kelley, K and Wunderlich, D and Mierz, D and Aune, T. (1991) Human T cell activation by OKT3 is inhibited by a monoclonal antibody to CD44 Journal of Immunology, 147, pp. 2493 - 2499.
35. Guo, Y and Lin, S and Wang, J and Bigby, M and Sy, M. (1994) Palmitoylation of CD44 interferes with CD3-mediated signaling in human T lymphomcytes International Immunology, 6, pp. 213 - 221.
36. Sugiyama, K and Komada, Y and Deguchi, T and Zhang, X and Azuma, E and Ido, M. (1999) CD3-mediated T cell activation is inhibited by anti-CD44 monoclonal antibodies directed to the hyaluronan-binding region Immunology Investigation, 28, pp. 185 - 200.
37. Lei, H and Tang, M and Tsao, N. (1997) Intracellular alkalinization in dexamethasone-induced thymocyte apoptosis Apoptosis, 2, pp. 304 - 312.
38. Tong, D and Buck, S and Roberts, B and Klein, J and Tumin, J. (2004) Calcineurin phosphatase activity: Activation by glucocorticoids and role of intracellular calcium Transplanation, 77, pp. 259 - 267.
39. Tonko, M and Ausserlechner, M and Bernhard, D and Helmberg, A and Kofler, R. (2001) Gene expression profiles of proliferating vs G1/G0 arrest human leukemia cells suggest a mechanism of glucocorticoid-induced apoptosis FASEB Journal, 15, pp. 693 - 699.
40. Wiman, K and Magnusson, K and Ramqvist, T and Klein, G. (1991) Mutant p53 detected in a majority of Burkitt lymphoma cell lines by monoclonal antibody PAb240 Oncogene, 6, pp. 1633 - 1639.
41. Sangfelt, O and Erickson, S and Einhorn, S and Grander, D. (1997) Induction of Cip/Kip and Ink 4 cyclin dependent kinase inhibitors by interferon-α in hematopoietic cell lines Oncogene, 14, pp. 415 - 423.
42. Dunkern, T and Wedemeyer, I and Baumgartner, M and Fritz, G and Kaina, B. (2003) Resistance of p53 knockout cells to doxorubicin is related to reduced formation of DNA strand breaks rather than impaired apoptotic signaling DNA Repair, 2, pp. 49 - 60.